ArticleBreast cancer research and treatment2025

Baseline hemoglobin and neutrophil-to-lymphocyte ratio as prognostic biomarkers in patients with metastatic triple negative breast cancer treated with sacituzumab govitecan in second line and beyond: a real-world analysis.

Małgorzata Pieniążek et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.